Early-Onset Alzheimer’s Disease Is Associated With Greater Pathologic Burden

Two subtypes of Alzheimer’s disease (AD) have been commonly identified: early- and late-onset forms. Previous studies suggest that early-onset AD patients have more neuritic plaques (NPs) and neurofibrillary tangles (NFTs). In the current study, NP and NFT counts were performed for 8 brain regions in 25 subjects with definite AD. A repeated-measures analysis of variance of mean regional NP and NFT counts for early- and late-onset groups was performed. A significant between-subject effect indicating greater overall NP and NFT burden in the early-onset group was observed (NP: F = 6.8, df = 1, P = .015; NFT: F = 7.5, df = 1, P = .012). This analysis supports the hypothesis that early-onset AD is associated with greater pathologic burden than late-onset AD. This suggests that late-onset AD patients have less cognitive reserve than early-onset patients and require fewer pathologic changes to exhibit cognitive deterioration.

[1]  Yaakov Stern,et al.  Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease , 2004, Current Neurology and Neuroscience Reports.

[2]  L. Thal,et al.  Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease , 2002, Neuroreport.

[3]  E. Bigio,et al.  Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis , 2002, Neuropathology and applied neurobiology.

[4]  Tiffany E. Chow,et al.  Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease , 2001, Annals of neurology.

[5]  J. Cummings,et al.  Alzheimer's disease , 1998, Neurology.

[6]  J. Price,et al.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.

[7]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[8]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[9]  Mark J. West,et al.  New stereological methods for counting neurons , 1993, Neurobiology of Aging.

[10]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[11]  R. DeTeresa,et al.  Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease , 1988, Neurology.

[12]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[13]  J. Cummings,et al.  Comorbidity in dementia: an autopsy study. , 2004, Archives of pathology & laboratory medicine.

[14]  Mark J West,et al.  Design-based stereological methods for counting neurons. , 2002, Progress in brain research.

[15]  P Pietrini,et al.  Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. , 1997, The American journal of psychiatry.

[16]  S. M. Sumi,et al.  Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. , 1993, Alzheimer disease and associated disorders.